Perivascular spaces as a potential biomarker of Alzheimer’s disease
Alzheimer’s disease (AD) is a highly damaging disease that affects one’s cognition and memory and presents an increasing societal and economic burden globally. Considerable research has gone into understanding AD; however, there is still a lack of effective biomarkers that aid in early diagnosis and...
Main Authors: | Miranda Lynch, William Pham, Benjamin Sinclair, Terence J. O’Brien, Meng Law, Lucy Vivash |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2022.1021131/full |
Similar Items
-
A critical guide to the automated quantification of perivascular spaces in magnetic resonance imaging
by: William Pham, et al.
Published: (2022-12-01) -
Perivascular spaces as a marker of disease severity and neurodegeneration in patients with behavioral variant frontotemporal dementia
by: Jasmine Moses, et al.
Published: (2022-10-01) -
Sodium selenate as a therapeutic for tauopathies: A hypothesis paper
by: Roxane Dilcher, et al.
Published: (2022-08-01) -
Role of the glymphatic system and perivascular spaces as a potential biomarker for post‐stroke epilepsy
by: Gernot Hlauschek, et al.
Published: (2024-02-01) -
The adaptation of the desirability of outcome ranking for interventional clinical trials in epilepsy: A novel consumer‐led outcome measure
by: Lucy Vivash, et al.
Published: (2023-12-01)